31650014|t|A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy.
31650014|a|INTRODUCTION: Neuroinflammation, which contributes to neurodegeneration, is a consistent hallmark of dementia. Emerging evidence suggests that systemic inflammation also contributes to disease progression. METHODS: The ability of systemically administered lipopolysaccharide (LPS - 500 mug/kg) to effect acute and chronic behavioural changes in C57BL/6 and P301S tauopathy mice was assessed. Markers of pathology were assessed in the brain and spinal cord. RESULTS: P301S mice display regional microgliosis. Systemic LPS treatment induced exaggerated acute sickness behaviour and motor dysfunction in P301S mice compared with wild-type controls and advanced the onset and accelerated chronic decline. LPS treatment was associated with increased tau pathology 24 hours after LPS injection and spinal cord microgliosis at the end stage. DISCUSSION: This is the first demonstration that a single systemic inflammatory episode causes exaggerated acute functional impairments and accelerates the long-term trajectory of functional decline associated with neurodegeneration in a mouse model of human tauopathy. The findings have relevance to management of human dementias.
31650014	18	30	inflammatory	Disease	MESH:D007249
31650014	107	112	mouse	Species	10090
31650014	122	127	human	Species	9606
31650014	128	137	tauopathy	Disease	MESH:D024801
31650014	153	170	Neuroinflammation	Disease	MESH:D000090862
31650014	193	210	neurodegeneration	Disease	MESH:D019636
31650014	240	248	dementia	Disease	MESH:D003704
31650014	291	303	inflammation	Disease	MESH:D007249
31650014	395	413	lipopolysaccharide	Chemical	MESH:D008070
31650014	415	418	LPS	Chemical	MESH:D008070
31650014	484	491	C57BL/6	CellLine	CVCL:C0MU
31650014	496	501	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0
31650014	512	516	mice	Species	10090
31650014	583	594	spinal cord	Disease	MESH:D013118
31650014	605	610	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0
31650014	611	615	mice	Species	10090
31650014	633	645	microgliosis	Disease	
31650014	656	659	LPS	Chemical	MESH:D008070
31650014	690	704	acute sickness	Disease	MESH:D000208
31650014	719	736	motor dysfunction	Disease	MESH:D000068079
31650014	740	745	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0
31650014	746	750	mice	Species	10090
31650014	840	843	LPS	Chemical	MESH:D008070
31650014	913	916	LPS	Chemical	MESH:D008070
31650014	931	942	spinal cord	Disease	MESH:D013118
31650014	943	955	microgliosis	Disease	
31650014	1041	1053	inflammatory	Disease	MESH:D007249
31650014	1087	1109	functional impairments	Disease	MESH:D003072
31650014	1189	1206	neurodegeneration	Disease	MESH:D019636
31650014	1212	1217	mouse	Species	10090
31650014	1227	1232	human	Species	9606
31650014	1233	1242	tauopathy	Disease	MESH:D024801
31650014	1289	1294	human	Species	9606
31650014	1295	1304	dementias	Disease	MESH:D003704
31650014	Association	MESH:D000068079	HGVS:p.P301S
31650014	Positive_Correlation	MESH:D008070	MESH:D000208
31650014	Positive_Correlation	MESH:D008070	MESH:D000068079
31650014	Positive_Correlation	MESH:D008070	HGVS:p.P301S
31650014	Association	MESH:D000208	HGVS:p.P301S
31650014	Positive_Correlation	MESH:D008070	MESH:D013118

